All In Biotech

Drug Trial Radar · NCT02134301

Open Label, Dose-finding, Pharmacokinetics, Safety and Tolerability Study of Oritavancin in Pediatric Participants With Suspected or Confirmed Bacterial Infections

An Open Label, Dose-finding, Pharmacokinetics, Safety, and Tolerability Study of Oritavancin Single Dose Infusion in Pediatric Subjects Less Than 18 Years of Age With Suspected or Confirmed Bacterial Infections

Last checked: Nov 19, 2026Latest source record: Dec 12, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

41

Actual

Start

May 2014

Primary completion

Nov 4, 2025

Study completion Nov 4, 2025

Sponsor

Lead sponsor
Melinta Therapeutics, LLCIndustry
Sponsor type
Industry
First posted
May 9, 2014

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 1
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
Who can join
All sexes, up to 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this Phase 1 trial is to evaluate the pharmacokinetics (PK), safety and tolerability of oritavancin in participants \<18 years old with a confirmed or suspected bacterial infection.

Conditions

  • Gram-positive Bacterial Infections

Interventions

  • OritavancinDrug

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Pharmacokinetic Parameter (Area under the plasma concentration time-curve [AUC])Time frame: 336 hours post infusion start time for Cohorts 1-4 and 168 hours for Cohort 5

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • Arkansas Children's Hospital

    Little Rock, Arkansas

  • Children's Hospital of Orange County

    Orange, California

  • Rady Children's Hospital

    San Diego, California

  • UCLA Harbor Medical Center

    Torrance, California

  • Univ of Louisville, Norton Children's Research Institute

    Louisville, Kentucky

  • University of Nebraska Medical Center

    Omaha, Nebraska

  • Rainbow Babies and Children's Hospital

    Cleveland, Ohio

  • Toledo Children's Hospital

    Toledo, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.